How to Choose the Best Trade Name for Glucagon: A Peptide Product Guide
Published: 18 7 月, 2026 16:21
Author: Simone Garcia
Abstract: Selecting an optimal trade name for glucagon requires navigating a complex peptide market projected to reach USD 68.9 billion by 2030 (CAGR 8.9%). This guide evaluates brand differentiation (e.g., GlucaGen vs. Baqsimi), comparing lyophilized powder (stability) vs. nasal spray (bioavailability). Key parameters include purity (>98% HPLC), endotoxin levels (<1 EU/mg), and cold-chain logistics (2-8°C). Regulatory compliance (FDA/EMA GMP certificates) and factory audits are critical. Applications span severe hypoglycemia to diagnostic imaging. Current brand consolidation (Novo Nordisk, Eli Lilly) demands rigorous supplier vetting for peptide integrity and supply chain resilience.